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Abstract
Transcriptome analysis of adult hematopoietic stem cells (HSC) and their progeny has revealed
mechanisms of blood differentiation and leukemogenesis, but a similar analysis of HSC
development is lacking. Here, we acquired the transcriptomes of developing HSC purified from
>2500 murine embryos and adult mice. We found that embryonic hematopoietic elements
clustered into three distinct transcriptional states characteristic of the definitive yolk sac, HSCs
undergoing specification, and definitive HSCs. We applied a network biology-based analysis to
reconstruct the gene regulatory networks of sequential stages of HSC development and
functionally validated candidate transcriptional regulators of HSC ontogeny by morpholino-
mediated knock-down in zebrafish embryos. Moreover, we found that HSCs from in vitro
differentiated embryonic stem cells closely resemble definitive HSC, yet lack a Notch-signaling
signature, likely accounting for their defective lymphopoiesis. Our analysis and web resource
(http://hsc.hms.harvard.edu) will enhance efforts to identify regulators of HSC ontogeny and
facilitate the engineering of hematopoietic specification.
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Introduction
Hematopoietic stem cells (HSC) have been extensively analyzed via global transcriptional
profiling, which has yielded novel insights into their unique biology (Seita and Weissman,
2010). A recent examination of human HSC and their progeny revealed both hematopoietic
cell-type specific and ‘re-used’ transcriptional programs (Novershtern et al., 2011). A
similarly comprehensive examination of the transcriptome of embryonic HSC is absent from
the literature, largely due to the practical difficulties of prospectively isolating sufficient
quantities of highly purified HSCs and precursors from embryos (Godin and Cumano,
2002). The description of Sox17 as a disparate regulator of fetal vs. adult HSC indicates that
distinct molecular pathways likely govern different stages of HSC development (Kim et al.,
2007). A deep understanding of the molecular regulation of HSC ontogeny would inform
efforts to expand HSC in vitro and induce HSC generation during pluripotent stem cell
(PSC) differentiation, as well as illuminate novel disease causing genes.
Definitive adult-type HSC are born in the E10.5 aorta-gonads-mesonephros (AGM), and
thereafter migrate to the fetal liver (FL), placenta, and bone marrow (Medvinsky et al.,
2011). HSCs apparently emerge from a subset of endothelial cells in the ventral aspect of the
dorsal aorta (recently reviewed in detail (Medvinsky et al., 2011)). Imaging reveals the
dramatic “bending” of hemogenic endothelial cells as they move into the aortic space (Kissa
and Herbomel, 2010). Although these emergent cells have not been directly demonstrated to
be functional HSC, the preponderance of evidence indicates that definitive HSC arise from
hemogenic endothelium.
Directed differentiation of PSCs to specific lineages for research and cell therapy is a major
goal of stem cell biology. Nearly two decades of effort has not yielded robust, definitive
HSC from PSC (McKinney-Freeman and Daley, 2007). Ectopic expression of the homeotic
genes HoxB4 and Cdx4 produced cells that reconstituted multi-lineage hematopoiesis in
lethally irradiated primary and secondary mice (Kyba et al., 2002; Wang et al., 2005b).
Although this approach generated hematopoietic progenitors with cardinal features stem cell
features of self-renewal and multi-lineage differentiation, these embryonic stem cell derived-
HSCs (ESC-HSC) do not faithfully mimic the function or phenotype of whole bone marrow
(WBM)-HSCs (Bonde et al., 2008; McKinney-Freeman et al., 2009; Tabayoyong et al.,
2009). Recent data proposing the equivalence of hemogenic endothelium and the
hemangioblast that arises during ESC differentiation (Lancrin et al., 2009) suggests that
discerning the molecular pathways of hematopoietic ontogeny in vivo will provide a
roadmap for differentiating definitive HSC from PSC in vitro.
Here, we present the most complete analysis of the transcriptional program of definitive
HSC ontogeny to date, gleaned from rigorously characterized hematopoietic stem and
progenitor cell (HSPC) populations isolated from over 2500 murine embryos and adult mice.
To illuminate combinatorial control of gene expression, we applied a novel computational
analysis that identifies a gene regulatory network for each critical developmental stage
(Faith et al., 2007). We then validated several predicted regulators in HSC ontogeny via
morpholino knock-down in zebrafish embryos. We discovered that HSC exist in only three
distinct transcriptional states during ontogeny and that a subset of HSC from E12.5 FL retain
the transcriptional signature of their endothelial precursors. Ultimately, we compared the
transcriptional profiles of ESC, ESC-derived hematopoietic progenitors, and ESC-HSC to
their potential in vivo counterparts, and found that ESC-HSC most closely resemble
definitive HSC but are defective in essential HSC regulatory pathways, perhaps accounting
for their functional deficits. Taken together, our unique dataset, available to the stem cell
community as a searchable web resource (http://hsc.hms.harvard.edu), illuminates novel
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aspects of hematopoietic development that will prove valuable for research in developmental
hematopoiesis and in vitro directed differentiation.
Results
Acquisition of HSC gene expression profiles throughout murine ontogeny
The technical challenges to purifying HSC to absolute homogeneity from FL and WBM has
not precluded the derivation of important biological insights from analysis of the global gene
expression profiles of highly purified populations of primitive hematopoietic progenitors
(Kiel et al., 2005; Park et al., 2003; Seita and Weissman, 2010). Here, we restricted our
purification scheme to surface markers that enrich functionally for hematopoietic
repopulation (yolk sac (YS), placenta, FL, WBM, and ESC-HSC) or HSC precursors (EB-
derived cells and AGM) (Figure 1A and Table 1). E9 YS CD41+c-kit+CD34+ cells can
contribute to life-long hematopoiesis when transplanted into neonates (Ferkowicz et al.,
2003). E11.5 AGM HSC are exceedingly rare (1-3 functional HSC per embryo;
(Kumaravelu et al., 2002)). However, between E11.5 and E12.5, HSC expand dramatically
in the placenta and FL (Kumaravelu et al., 2002; Taoudi et al., 2008; Taoudi et al., 2005).
This expansion results partly from an acceleration in de novo HSC specification from VE-
cadherin+CD45+ AGM hemogenic precursors (Taoudi et al., 2008). To capture the
molecular transition from hemogenic endothelium to definitive HSC, we isolated VE-
cadherin+CD45+ cells from E11.5 AGM and HSC from E12.5 placenta and FL. We also
collected HSC from E13.5 FL, E14.5 FL, adult WBM, and ESC (McKinney-Freeman et al.,
2008). Samples were double sorted into lysis buffer via fluorescence activated cell sorting to
assure cell purities of >95%, minimal loss of material, and maximal RNA integrity (Figure
1B, Figure S1). Three to six biological replicates were collected for each population. We
generated gene expression profiles using Affymetrix gene chips and performed
computational analysis as described below.
Embryonic HSC exist in three predominant transcriptional states
Pearson correlations between biological replicates revealed that most samples within a group
were well correlated (Figure S2A). Hierarchical clustering and principal component analysis
(PCA) reveal that embryonic hematopoietic populations segregate into three
transcriptionally distinct groups, designated as “Yolk Sac-like”, “Specifying HSC”, and
“Definitive HSC” (Figure 2A and B). Placenta and AGM samples cluster together (Figure
2A and B), confirming recent data that both are sites of hematopoietic specification (Rhodes
et al., 2008). Interestingly, two E12.5 FL samples align with the AGM, whereas four align
with later stage FL and WBM HSC (Figure 2A). We termed the AGM-like E12.5 FL
samples “FL12 A”, and the FL-like E12.5 FL samples “FL12 F”. FL12 F, E13.5 FL, E14.5
FL, and WBM-HSC cluster as one group (i.e. “Definitive HSC”) while E9 YS cluster
separately with embryoid-body (EB)-derived hematopoietic progenitors. Definitive HSC
isolated from FL across two days of embryonic development (E12.5-14.5) are nearly
indistinguishable by gene expression. Nine genes were differentially expressed in FL12 F
vs. E13.5 FL and only five genes distinguished E13.5 from E14.5 (http://
hsc.hms.harvard.edu). In contrast, 619 genes were differentially expressed between AGM
and FL12 F HSC (http://hsc.hms.harvard.edu). The clustering of FL12 A with placenta/
AGM rather than FL/WBM suggests that the transcriptional signature of HSC immediately
upon arrival in the FL represents a critical transitional stage from hemogenic endothelium to
definitive HSC that can be observed fortuitously in some embryos (Figure 2A and B).
Although AGM and FL12 A cluster together, they are transcriptionally distinct when
specific hematopoietic genes are examined (Figure S2B). In total, our data reveal that AGM
and FL12 A are distinct, yet transcriptionally related cell populations.
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To determine whether differences in the HSPC gene regulatory network (GRN) contribute to
the three distinct transcriptional states of developing HSC, we first identified the context-
dependent GRNs of 44 distinct cell types and tissues, including HSPCs, using publicly
available data (Supplemental Methods). There are three components to each GRN: genes
expressed by a cell type or tissue, the transcription factors (TFs) predicted to regulate these
genes, and cooperating gene sets that must be highly expressed for the TFs to exert a
regulatory influence (contexts). We compared the expression of the HSPC GRN in YS and
AGM to WBM (Figure 2C). The expression of the HSPC regulators Erg, Nfe2, Hoxa9, and
Hlf, did not reach an adult HSC expression level in the YS and AGM. Also, Tulp4, a
predicted repressor of the HSPC GRN, is highly expressed in both the YS-like and
Specifying HSC. However, Myb, Gata2, Tal1, Etv6, Prdm5, and Homez had low expression
only in Specifying HSC, suggesting that this difference contributes to the distinct states of
the YS-like and Specifying groups. Examining the progression of GRN changes in the
Definitive HSC population from FL12 to FL14, we found that Fos and Fosb are down-
regulated in highly proliferative FL HSCs (Figure 2C), consistent with their role as gate-
keepers to HSC mitotic entry (Okada et al., 1999).
Hemogenic endothelial HSC precursors share transcriptional overlap with macrophages
Our data represent the first global expression profiling of HSPC and their precursors from
the AGM, YS, and placenta. To determine the global resemblance of these populations to
known, adult cell populations, we applied a Naive Bayesian classifier that calculates the
probability that an unknown sample is indistinguishable from known cells types and tissues
(Supplemental Methods). HSC from WBM, FL12 F, E13.5 FL, E14.5 FL, E9 YS, E12.5
placenta, E11.5 AGM, day-6 EB-derived cells, and ESC-HSC cells all classified as HSPCs
(Figure 3A). Surprisingly, E11.5 AGM hemogenic precursors also scored positively for
similarities to macrophages, microglia and osteoclasts. This likely does not result from
contamination because the E11.5 AGM population is uniformly composed of small, blast-
like cells that do not resemble macrophages (Taoudi et al., 2005). The set of genes
contributing most significantly to the macrophage classification (Figure S3A) is enriched in
the GO Biological Processes ‘Cell migration’, ‘Blood vessel development’, and
‘Inflammatory response’ (corrected p-values<0.01), suggesting that AGM-derived cells and
macrophages utilize common genetic programs to facilitate their migratory behavior and that
these cells have remnants of their endothelial origin. The FL12 A samples also classified as
macrophages, despite being isolated on the basis of a distinct cell surface phenotype that
included the depletion of mature hematopoietic lineages, including macrophages.
We speculated that differential activity of the regulatory network governing the macrophage
program might account for the ability of hemogenic endothelial cells to transiently pass
through a macrophage-like transcriptional state. To explore this, we again leveraged the
context-dependent GRNs of 44 cell types and tissues, comparing the expression of the
macrophage GRN in the AGM and FL-derived HSCs to primary macrophages. The
expression of most macrophage positive regulators was unchanged (Figure 3B) in the AGM
and FL12 A samples. However, Sfpi1, a master regulator of myeloid and lymphoid
differentiation, does not reach the macrophage level of expression (Figure 3B). This is
significant because Sfpi1 is auto-regulated in differentiated myeloid cells, a mechanism by
which cells are able to stabilize transcriptional states (Leddin et al., 2011). These results
suggest a model in which nascent HSCs temporarily access a macrophage-related
transcriptional program, perhaps to facilitate their migration to the FL. Low Sfpi1
expression may ensure that this state is transient.
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ESC-derived hematopoietic progenitors and HSC cluster with distinct in vivo populations
EB-derived hematopoietic progenitors express c-kit and CD41 (McKinney-Freeman et al.,
2008; Mikkola et al., 2003) and acquire repopulating activity when exposed to ectopic
homeobox gene expression and OP9 co-culture (Wang et al., 2005a). Moreover, retroviral
integration site analysis reveals clonal multi-lineage lymphoid-myeloid engraftment of
primary and secondary animals, thereby reflecting the cardinal features of HSCs—self-
renewal and multipotency (Wang et al., 2005a). Although Cdx-Hox modified EB cells are
the most robust ESC-HSC reported to date, they fail to fully reconstitute the in vivo
lymphoid compartment and display an aberrant cell surface phenotype (McKinney-Freeman
et al., 2009). A better understanding of how these ESC-HSC relate to embryonic HSCs
would inform protocols for deriving HSC from PSC or non-hematopoietic tissues via direct
conversion. Thus, we compared the gene expression profiles of CD41BrightCD34-CD45-
ESC-HSC, c-kit+CD41+ day-6 EB-derived cells, and ESC to the developmental dataset
(Figure 1 and Table 1). ESC-HSC cells clustered mostly tightly with FL and WBM HSC
(Figure 2A and B) and were distinct from mid-gestation in vivo populations (i.e. E9 YS) and
their cells of origin (i.e. c-kit+CD41+ EB-derived cells). As anticipated, EB-derived c-
kit+CD41+ cells clustered with E9 YS, reflecting the known similarity of EB-derived and
YS hematopoiesis (Keller et al., 1993). Thus, despite their aberrant function, ESC-HSC are
most similar to HSC populations with a definitive, adult-like HSC fate.
Pair-wise comparisons
As the expression of few known HSC regulators fluctuated during HSC ontogeny (Figure
S2B), we next assessed differentially expressed genes between each population for
enrichment of Gene Ontology (GO) biological processes and canonical signaling pathways
(Figure S4A and B). Gene Set Enrichment Analysis (GSEA) was applied to pair-wise
comparisons between all populations and major biological groups (i.e. YS-like, Definitive,
and Specifying HSCs). As expected, ESC were enriched in the GO category “negative
regulation of cell differentiation,” and all embryonic populations were enriched in active cell
cycle categories (e.g. “cell division”, “cell cycle”, and “mitosis”) relative to WBM-HSC,
consistent with their known quiescence (Wilson et al., 2009). VE-cadherin+CD45+ AGM-
derived cells were enriched for “cell communication”, “NO biosynthetic processes”, and
“positive regulation of angiogenesis” (Figure S4A), reflective of their endothelial origin.
AGM and placenta were both enriched for “neutrophil chemotaxis” and “chemotaxis”,
suggesting migratory populations. AGM and placenta are also enriched in “inflammatory
response” and “response to lipopolysaccharide” (Figure S4A), consistent with a
transcriptional resemblance to macrophages (Figure S4A). Analysis of the major biological
groups revealed that Specifying HSCs were enriched in chemotaxis, inflammatory response,
positive regulation of nitric oxide, biosynthetic process, cell adhesion, positive regulation of
angiogenesis, and the ERK cascade, again consistent with an endothelial origin (Figure 4A)
(Krens et al., 2008; Srinivasan et al., 2009).
Next, we determined whether genes regulated in response to the twenty NetPath signaling
pathways (Kandasamy et al., 2010) were enriched in the YS-like, Definitive, and Specifying
populations. Each NetPath-annotated signaling pathway has two gene sets: genes up-
regulated in response to a pathway and genes down-regulated. Genes up-regulated in
response to Wnt and IL-3 signaling were enriched in Specifying HSC (Figure 4B), in
agreement with reports that Wnt and IL-3 signaling promote HSC specification (Goessling
et al., 2009; Robin et al., 2006). Notably, in vivo Definitive HSCs were enriched in genes
targeted by Notch signaling relative to ESC-HSC (Figure 4B and Figure S4B), suggesting
that the aberrant functionality of ESC-HSC may be due to a lack of specification via Notch
signaling.
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Identification of known and novel transcriptional regulators of HSC ontogeny
To identify coordinately expressed genes, we applied the network-based Weighted Gene Co-
expression Network Analysis clustering algorithm (WGCNA) and detected 66 modules
ranging in content from 24 to 1,752 genes (Figure 5 and Figure S5A). A complete list of
genes assigned to each module is available on the companion website (http://
hsc.hms.harvard.edu). As genes within a module are highly positively correlated, we
summarized their expression as the median of the standardized expression of each gene
within a given module, resulting in a single module value at each developmental time-point
(Figure 5 and Figure S5A). Twenty-six modules are stage-enriched (i.e., more highly
expressed in a single stage than all other stages (corrected P-value<0.01; Figure 5)). Thirteen
modules were characteristic of Definitive HSC (highest in FL12 F, FL13, FL14, WBM,
ESC-HSC), 11 for Specifying HSC (highest in AGM, Placenta, FL12 A), 5 for Yolk sac-like
(highest in EB and YS), and 10 reflected the in vitro state (highest in ESC, EB, and ESC-
HSC; Figure 5).
To identify the GRN active in HSC development, we used the Context Likelihood of
Relatedness (CLR) algorithm to identify putative transcriptional regulators (TR) of each
module (Figure S6A) (Faith et al., 2007; Taylor et al., 2008). CLR uses mutual information
rather than linear correlation to identify significant relationships between TR and target
genes, and has accurately reconstructed mammalian GRN (Faith et al., 2007; Taylor et al.,
2008). We applied CLR to each gene module and 1,623 TRs, computing the mutual
information between module profiles and the expression profile of each TR. This analysis
identified a GRN consisting of 1,147 putative regulatory relationships (FDR<0.05) with 0 to
53 (median=17) regulators per module and 0 to 7 modules per regulator. A table of the
complete GRN (TRs and putative target modules) is available on the companion website.
For clarity, we show the network consisting of CLR predictions at the 0.01 FDR threshold
(Figure S6A). The network is scale-free, indicating that a small number of nodes act as hubs
with edges to a large number of other nodes, consistent with other network analyses of GRN
(Figure S6B) (Barabasi and Oltvai, 2004).
To assess the reproducibility of our gene expression data, we analyzed the exemplars and
top three predicted regulators of 22 modules via the Fluidigm microfluidic qRT-PCR
platform (Table S1, Figure S5B-E). We collected multiple additional independent biological
replicates of EB-derived cells, ESC-HSC, YS, Placenta, AGM, E12.5 FL, E13.5 FL, and
WBM (Table 1) and compared the microarray intensities of each gene at each stage to qRT-
PCR-based delta Cts (normalized to Rps29). We saw high concordance between the two
platforms (R2=0.5446, P-value<4.4 * 10-111, Figure S5C and D). Figure S5E depicts the
results for five “Definitive HSC” modules, revealing that at the gene-level, the Affymetrix-
expression levels are recapitulated by Fluidigm. In total, 60/80 candidate genes (at a P-value
cutoff <0.10) were validated by Fluidigm, confirming the fidelity of our dataset.
Hypothesizing that highly connected (“hub”) genes are more likely to be important in HSC,
we looked for overlap in the CLR predictions of modules with a “Definitive HSC” signature
(i.e., M7, M10, M11, M12, M23, M26, M35, M37, M42, M50, M8 and M9; Figure 6A).
Regulators predicted for more than one of these modules are labeled in Figure 6A. Many of
these “hub” regulators have already been implicated in hematopoiesis, though not
necessarily in HSC development, including HoxA9, Vdr, Hlf, Lmo2, Bcl11a, Prdm16, Gfi1,
and Mllt3 (Chuikov et al., 2010; Hirose et al., 2010; Hock et al., 2004; Jeanson and Scadden,
2010; Lawrence et al., 1997; Magnusson et al., 2007; Pina et al., 2008; Sankaran et al.,
2008). These results confirm that “hub” genes may be key regulators of HSC function and/or
development.
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To functionally determine if our computational predictions were indeed able to identify
novel gene candidates involved in definitive hematopoiesis, Definitive HSC “hub” genes
prdm16, mllt3, atf3, msrb2 and rfx5 (Figure 6A), as well as gfi1b, predicted regulator of
definitive module M10, and tulp4, a CLR predicted positive regulator of Specifying modules
19 and 28 and negative regulator of Definitive HSC module 7, were selected for knock-
down in zebrafish embryos. Mllt3 is also a Specifying “hub” gene, predicted to regulate two
Specifying modules (M28 and M40). Zebrafish represents a tractable system that faithfully
reflects mammalian hematopoiesis and thus, allows us to rapidly interrogate a role for these
genes in this process in vivo. Embryos were injected at the one-cell stage with morpholinos
targeting these gene candidates and assayed at 36 hours post fertilization (hpf) by in situ
hybridization for c-myb and runx1, markers for HSPC/myeloid cells and HSPC, respectively
(Jin et al., 2009).
mllt3 morphants displayed a significant loss of both c-myb and runx1 staining in the 36 hpf
AGM, suggesting a decrease in HSPC (Figure 6B). While disruption of gfi1b did not affect
c-myb or runx1 expression in the AGM, an increase of c-myb+ cells and a decrease of
runx1+ cells was seen in the posterior intermediate cell mass (ICM), where erythroid/
myeloid progenitors (EMP) are known to localize (Figure 6B). These data implicate gfi1b in
erythroid/myeloid EMP fate choice by suggesting an increase in EMP-derived myeloid
progeny, consistent with gfi1’s known role in lineage choice (Hock and Orkin, 2006;
Randrianarison-Huetz et al., 2010). Atf3 morphants showed an increase in runx1 staining in
the AGM with no change in c-myb staining (Figure 6B). Likely aft3 directly or indirectly
regulates runx1 transcript levels, given that aft3 morphants also displayed no change in l-
plastin or CD41, suggesting that myeloid progeny downstream of HSPC, as well as HSPC
progenitors, respectively were unchanged (Figure S7B and C). Tulp4 morphants showed a
decrease in both runx1 and c-myb staining in the AGM, suggesting a reduction in HSPC
(Figure 6B). Neither Atf3 nor Tulp4 have ever been linked functionally to the regulation of
HSC or hematopoiesis. Thus, our computational data effectively identified these two genes
as putative novel regulators of HSPC biology.
C-myb expression was clearly reduced in prdm16 morphants while runx1 expression was
maintained (Figure 6B). A loss of c-myb/runx1 staining was also observed with a second
morpholino targeting a distinct exon of prdm16 (Figure S7 A and D). The development of c-
myb+/runx1+ cells in the caudal hematopoietic tissue was also impaired in prdm16
morphants at four days post fertilization (dpf) (Figure 6C). This was not concomitant with
an initial loss of proliferation or increase in cell death, as we observed no changes in
phospho-histone H3 or apoptosis in prdm16 morphants (Figure S7E). Impairment in the
formation of mpo+ and l-plastin+ myeloid cells and rag1+ lymphoid cells was also observed
at 38 hpf and four dpf respectively (Figure 6D and E). Notch1 signaling, ephrinB2
expression, and flk1 expression were all unperturbed in prdm16 morphants, supporting
intact hematopoietic and endothelial specification (Figure S7F and G). These data suggest
proper HSC specification in prdm16 morphants, but a failure of HSCP maintenance, and
possibly differentiation, as has been suggested by recent mouse studies (Chuikov et al.,
2010; Aguilo et al., 2011). However, a potential defect in HSC migration cannot be
excluded by these experiments.
Discussion
Here we present a comprehensive analysis of the transcriptome of developing HSC, from
mid-gestation through adulthood. By novel application of the network-based WGCNA and
CLR algorithms, we identified genes that define discrete stages of HSC development and
their putative regulators. As leukemic transformation often involves the reactivation of
developmental genes (e.g. Lmo2, Scl, Mll, Runx1 (Ernst et al., 2002; Izraeli, 2004)),
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understanding the transcriptional networks governing HSC development may help unravel
mechanisms of hematopoietic malignancy. Further, our dataset nominates a host of genes to
test for their potential to engineer hematopoietic fates from PSC, a critical milestone in
realizing the clinical potential of patient-specific PSC.
Our dataset complements a recent analysis of the transcriptional circuitry of human post-
natal hematopoietic populations by focusing on the transcriptional landscape of embryonic
hematopoiesis (Novershtern et al., 2011). Pbx1 and Sox4, identified in our analysis as
regulators of Definitive HSC modules M8 and M7, respectively, were also the top-level
regulators of the human ‘HSC-Progenitor’ program #865 in this prior study, suggesting
conservation of HSC regulators in humans and mice (Novershtern et al., 2011). However,
although the HSC-Progenitor program included HOXA9, HOXA10, GATA2, and MEIS1,
these genes were split here between modules M7 (Hox genes) and M8 (Gata2 and Meis1),
suggesting that the establishment of the HSC transcriptional program results from multiple,
distinct regulatory programs active during development. Thus, our novel analysis allowed us
to further refine distinct regulatory programs active during HSC ontogeny.
Identification and functional validation of novel transcriptional regulators
Computational strategies for inferring mammalian gene regulatory networks include
modeling expression levels using ordinary differential equations (di Bernardo et al., 2005;
Ergun et al., 2007), inferring regulatory relationships based on mutual information between
regulators and target genes, and Bayesian network approaches (Faith et al., 2007; Margolin
et al., 2006; Segal et al., 2003). As most known hematopoietic regulators in our data set did
not dramatically change expression in HSPC or their precursors during development (Figure
S2B), we presumed that the regulators that orchestrate the transitions responsible for each
developmental stage remained to be discovered and validated. Thus, we designed a novel
computational strategy to identify stage-specific transcriptional regulators. We applied the
CLR algorithm because of its strong performance characteristics and relatively short
execution times, which allowed us to iteratively run the algorithm as additional samples
were collected and processed (Ciaccio et al., 2010). By extending its application to modules
of coordinately expressed genes, we increased CLR s ability to detect putative targets genes
(Michoel et al., 2009). This allowed us to discern 66 distinct gene modules and associated
TRs. Each module represents an opportunity to develop novel hypotheses about the
regulation of HSC development. Our data is available to the community via a searchable
website (http://hsc.hms.harvard.edu) that allows users to both explore each WGCNA-
generated gene module and it s corresponding CLR-predicted TRs, as well as evaluate the
expression of genes of interest across the dataset.
Our zebrafish studies confirmed a role for prdm16, mllt3, gfi1b, aft3, tulp4, but not rfx5 and
msrb2 (data not shown), in HSPC biology. These genes were all predicted as HSC regulators
by our dataset and represent both known and novel hematopoietic factors. Our data
implicate for the first time potential roles for both Mllt3 and Tulp4 in HSC specification.
Importantly, both these genes are Specifying “hub” genes: Mllt3 is a predicted regulator of
Specifying modules M40 and M28 and Tulp4 of Specifying modules M28 and M19.
Although Mllt3-/- deficient mice do not have peripheral hematopoietic defects, their HSC
compartment is unexplored (Collins et al., 2002; Iida et al., 1993). Preliminary work
suggests that ectopic Mllt3 during murine ESC differentiation enhances the specification of
hematopoietic progenitors (McKinney-Freeman, unpublished data). Prdm16, gfi1b, and atf3
were each shown to contribute to different aspects of HSC biology, likely downstream of
specification: gfi1b was shown to skew the activity of posterior ICM EMPs, consistent with
known roles in erythoid/megakaryocyte biology (Hock and Orkin, 2006; Randrianarison-
Huetz et al., 2010). Zebrafish prdm16 seems required to maintain homeostasis as HSC
differentiate, in agreement with recent data that mice require Prdm16 for HSC maintenance
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and function (Aguilo et al., 2011; Chuikov et al., 2010). Although Atf3 and Tulp4 were
predicted to regulate multiple Specifying and Definitive HSC modules by our analysis, these
two genes have never been previously linked to HSC biology. Our finding that morpholino-
mediated disruption of these genes in developing zebrafish can perturb the expression of key
hematopoietic TRs suggests that these genes may indeed regulate HSC development and/or
biology, although further work is needed to clarify their precise roles. Nonetheless, here we
showed that multiple genes identified by our computational strategy do indeed have
functional consequences on developing hematopoietic populations when disrupted in vivo,
establishing that this dataset and analysis can identify functionally relevant novel gene
candidates.
Recent reports establishing hemogenic endothelium as the source of definitive HSC have
generated tremendous interest in elucidating the molecular mechanisms governing this
transition. HoxA3, reported to suppress the hematopoietic signature in endothelium
(Iacovino et al., 2011) was identified in our study as a repressor of the specifying module
M28 (Figure 5). Erg, key for fetal HSC but dispensable for specification, is negatively
correlated with M19, a specifying module, but positively correlated with M10, a definitive
HSC module (Figure 5), exactly as one would predict (Taoudi et al., 2011). Thus, our
computational analyses successfully identified and classified these known regulators of HSC
development.
Embryonic HSC can be “YS-like”, “Specifying”, or “Definitive”
When examined by hierarchical clustering and PCA, the multiple independent HSPC
populations interrogated in our study converged on three transcriptionally distinct states: the
neonatal repopulating cells of the YS, the nascent HSC and precursors of the placenta and
AGM, and definitive FL and WBM HSC (Figure 2A and 2B). The relatively few differences
within these groups seen by differential expression and GSEA supports our conclusion that
there are three states of developing HSC. For example, pathway enrichment analyses
revealed only nine and six differentially expressed categories when E13.5 or 14.5 FL HSC
were compared with WBM-HSC, respectively. Seven of these nine differential groups relate
to the already well-described differences in cell cycle status between these groups (Figure
S4A). In contrast, 17 and 21 differential groups are seen when the AGM is compared to
E13.5 or 14.5 FL HSC, respectively, suggesting a distinct state. This finding also suggests
that the definitive HSC signature is not acquired gradually during gestation, but is specified
suddenly around E12.5 as HSC transition to the FL. This finding highlights again the critical
importance of dissecting the molecular regulation of the conversion from a “Specifying” to a
“Definitive” HSC fate, as this is the most dramatic and critical transition that occurs during
HSC ontogeny.
The E12.5 HSC compartment is split between two transcriptional states
HSC, rare in the E10.5-E11.5 conceptus, expand dramatically in the FL and placenta
between E11.5 and E12.5 due to an acceleration of de novo HSC specification (Taoudi et al.,
2008) (Mikkola et al., 2005). Surprisingly, hierarchical clustering and PCA of our data
reveal that the E12.5 HSC compartment is split between an AGM-like transcriptional
signature and a WBM-like transcriptional signature: all placenta and FL12 A samples
clustered with VE-cadherin+CD45+ E11.5 AGM while all FL12 F, E13.5 FL, and E14.5 FL
samples clustered with WBM HSC. Thus, some E12.5 HSC share significant transcriptional
overlap with hemogenic endothelial precursors. This could be due to ongoing HSC
specification within the early FL or significant numbers of nascent HSC newly arrived from
the AGM that have not yet silenced the hemogenic endothelial signature. While VE-
cadherin+CD45+ E11.5 AGM cells express only gamma globin, FL12 A cells express a
variety of fetal and adult hemoglobin genes, suggesting a population in transition. Thus, our
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unique data set and computational analyses suggest a model in which HSC originating from
AGM hemogenic endothelial precursors, and possibly placenta, seed the E12.5 FL and
acquire a complete definitive HSC signature over the next few hours of development.
Nascent HSC share transcriptional overlap with macrophages and inflammatory cells
Although VE-cadherin+CD45+ AGM-derived and FL12 A cells scored as HSPC, they also
correlated with macrophages via the Naïve Bayesian classifier (Figure 3A and Figure S3A).
E11.5 AGM-derived VE-cadherin+CD45+ cells are a mixture of hematopoietic progenitors,
adult repopulating cells, and hemogenic precursors that display a uniform ‘blast-like’
morphology very unlike macrophages (Taoudi et al., 2005). Our data suggest that the AGM
is enriched for nascent HSPC that utilize similar molecular mechanisms as macrophages to
migrate to the FL. Indeed, analysis of intra-aortic cell clusters by electron microscopy reveal
fillipodia extensions, suggestive of a population primed to migrate (Medvinsky et al., 1996).
VE-cadherin+CD45+ are likely found in these cell clusters (Taoudi et al., 2005). Like these
nascent progenitors, inflammatory cells are programmed to migrate (sites of infection vs.
FL). Live imaging recently captured dramatic changes in cell shape and motility as
endothelial cells leave the aortic wall and commit to a hematopoietic fate (Kissa and
Herbomel, 2010). It is possible that this process employs the same motility pathways as
macrophages.
ESC-HSC transcriptionally resemble definitive HSC
There have been many unsuccessful attempts to generate PSC-HSC (McKinney-Freeman
and Daley, 2007). Recently, hematopoietic cells have been generated via co-culturing
human ESC with AGM-derived stromal lines or reprogramming committed cells directly
into hematopoietic progenitors without a pluripotent intermediate, but the degree of
hematopoietic engraftment for these engineered populations lags behind accessible human
sources like umbilical cord blood (Ledran et al., 2008; Szabo et al., 2010). Although murine
ESC-HSC can robustly engraft lethally irradiated mice (Wang et al., 2005a), they do not
faithfully mimic the function or phenotype of WBM-HSC (McKinney-Freeman et al., 2009).
Since ESC-HSC express high levels of CD41, we hypothesized that they might represent a
developmental intermediate. However, our data reveal that ESC-HSC cluster most closely
with FL and WBM-HSC, rather than E9 YS or day 6 EBs. While it has been thought that
HoxB4 merely expands a hematopoietic progenitor population already specified during EB
differentiation, our results suggest that homeotic gene expression, in conjunction with OP9
co-culture, serves to re-specify a subset of CD41+ckit+ EB-derived cells towards a definitive
HSC fate, as originally argued (Kyba et al., 2002). The aberrant function of ESC-HSC is
likely due to incomplete specification or molecular perturbations caused by constitutive
ectopic homeobox gene expression and the absence of critical exogenous and molecular
cues. Indeed, Tek and HoxA9 expression is starkly absent from ESC-HSC relative to FL and
WBM HSC. Tek (also known as Tie2) regulates HSC maintenance while HoxA9 is required
for normal hematopoiesis (Arai et al., 2004; Lawrence et al., 1997; Takakura et al., 1998). In
addition, pair-wise comparison between ESC-HSC and FL/WBM HSC revealed the absence
of a transcriptional response to Notch signaling, which could explain the inability of these
cells to faithfully generate lymphoid cells. Further work is required to determine if rescuing
the Notch transcriptional response restores the lymphoid potential of homeobox-derived
ESC-HSC. Most importantly, since ESC-HSC are closely related to definitive HSC, yet
functionally restricted, they represent a unique opportunity to uncover novel molecular
regulators of definitive HSC function.
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Experimental Procedures
Details on embryo dissections, cell culture, zebrafish, fluidigm validation experiments, and
data analysis are described in the Extended Experimental Procedures available on-line.
Cell fractionation
Cell sorting was performed as previously described (McKinney-Freeman et al., 2009). For
all populations, cells were first collected in PBS and then sorted a second time into lysis
buffer (RNAeasy Microkit, Qiagen).
Microarray
The RNAeasy microkit (Qiagen) was used to collect and prepare total RNA for microarray
and Fluidigm analysis. The Ovation®Picokit (Nugen) was used for pre-amplification. Gene
expression profiling was performed on Affymetrix 430 2.0 gene chips per standard protocol.
Computational Analysis
Normalization, batch correction, differential analysis, and hierarchical clustering of
microarray data are described in detail in the Supplemental Methods. WGCNA, a clustering
algorithm that selects clustering cutoffs such that the resulting gene network follows a scale-
free distribution (Zhang and Horvath, 2005), was used to find sets of positively co-regulated
genes. Module profiles were computed by calculating the sample-median of standardized
gene expression values in each module. Module regulatory networks were constructed by
applying the CLR algorithm to the matrix consisting of the standardized expression values
of 1,171 transcription regulators detected as present in at least one biological group and the
module profiles. False discovery rates were calculated as previously described (Faith et al.,
2007). Stage-specific and stage-enriched modules were defined as those expressed higher in
one stage versus all other stages (Holm corrected p-value<1*10-10 and p-value<1*10-2,
respectively). GEO accessions of the mESC samples are GSE16925 and GSE14012.
Positive control samples for the classification analysis (Figure 3B) are GSM516564 and
GSM463712 for the macrophage and HSC samples, respectively. The GEO accession for
the newly generated data presented here is GSE37000.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• Web-based expression resource of embryonic blood populations: http://
hsc.hms.harvard.edu/
• Gene regulatory network reconstruction of HSC development
• Multiple novel regulators of HSC development implicated, e.g. Prdm16, Mllt3,
Gfi1b, Atf3, Tulp4
• ESC-HSCs resemble definitive HSC but lack a Notch-signaling signature
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Figure 1. Acquisition of global gene expression profiles of HSC compartments throughout
murine ontogeny
(A) Outline of the developmental time-points, embryonic tissues, and ESC-derived
populations examined. See also Figure S1. (B) RNA was collected from double sorted cells,
amplified, and then hybridized to 430 2.0 Affymetrix gene chips. The resulting data was
analyzed by unsupervised hierarchical clustering, PCA, Naïve Bayesian classifier, WGCNA,
GRN reconstruction by CLR, differential expression analysis, and GSEA prior to functional
studies in zebrafish.
McKinney-Freeman et al. Page 17
Cell Stem Cell. Author manuscript; available in PMC 2013 May 02.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 2. Identification of distinct transcriptional and regulatory stages of HSC ontogeny
Results of unsupervised hierarchical clustering (A) and PCA (B). (C) Schematics of the
HSPC gene regulatory network (GRN) in YS, AGM, FL12 F, FL13, and FL14 relative to
WBM HSC. This GRN is composed of HSPC expressed genes (center rectangle),
transcription factors (TFs) predicted to regulate these genes (circles), and cooperating gene
sets that must be highly expressed for the TFs to exert a regulatory influence (contexts,
boxed areas). Stimulatory TFs are shown as arrows and inhibitory TFs are shown as blunt
lines. Differences in TFs expression are shown as red circles (up-regulated) or blue circles
(down-regulated). Only TFs where the absolute value of the log2 ratio of the given sample
versus WBM HSCs exceeds 1 are shown. See also Figure S2.
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Figure 3. Comparison of HSCs in ontogeny to adult tissues and cell types
(A) A Naïve Bayesian classifier was used to assess transcriptional overlap with 44 tissues
and cell types. The results of 20 of these comparisons are displayed (all other reference
tissues and cell types were negative). NPC, neural progenitor cells; RPE, retinal pigment
epithelium; SM, skeletal muscle; CM, cardiac muscle; Mac, macrophage; MEP,
megakaryocyte-erythrocyte progenitor; CMP, common myeloid progenitor; GMP,
granulocyte-monocyte progenitor. Each row is a biological group (i.e. WBM HSCs), and
each column is a known tissue or cell type. The classifier determines the posterior
probability that a sample is indistinguishable from each of the tissues or cell types in the
reference data set. Higher probabilities are bright yellow and low probabilities are dark
green and black. (B) Schematics of the macrophage GRN in AGM, FL12 A, FL12 F, FL13,
and FL14 relative to primary macrophages (see Figure Legend 2C for details). Only TFs
where the absolute value of the log2 ratio of the given sample versus primary macrophages
exceeds 2 are shown. See also Figure S3.
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Figure 4. Pathway enrichment analysis of pair-wise comparisons between major developmental
hematopoietic groups
(A) GSEA of pair-wise comparisons to find GO Biological Processes enriched (red) or
depleted (blue) between developmental populations. (B) GSEA of pair-wise comparisons to
identify NetPath-annotated signaling pathways transcriptionally activated or suppressed. “In
vivo Definitive HSC” includes WBM, FL12 F, E13.5 FL and E14.5 FL; “Specifying HSC”
includes AGM, FL12 A, and placenta; “YS-like” includes EB and YS; and “All definitive
HSC” includes ESC-HSC, WBM, FL12 F, E13.5 FL and E14.5 FL. Only significant gene
sets are shown (Family wise error rate<0.05). See also Figure S4.
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Figure 5. Identification of stage-specific gene sets
Co-regulated gene sets were identified via WGCNA. 66 distinct modules were discovered.
A module was considered “Definitive HSC” if its expression was significantly higher in
definitive HSC (FL12 F, FL13, FL14, ESC-HSC, and WBM) relative to other samples
(Holm-corrected p-value<0.01). Similarly, modules were annotated as “stage-enriched”,
“specifying”, or “in vitro”. Each row represents the module profile: a summary of the
expression pattern of all genes within a module. See also Figure S5 and Table S1.
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Figure 6. Identification and validation of novel transcriptional regulators of discrete stages of
HSC ontogeny
(A) CLR was applied to identify putative TRs for each module. A network schematic of the
CLR-derived predictions at the 0.05 FDR for all “Definitive HSC” modules is shown. Pink
squares represent modules and blue circles represent predicted TRs. “Hub” genes are labeled
black. Genes assessed functionally in zebrafish are highlighted in red. A list of all genes
predicted to regulate each module can be found at http://hsc.hms.harvard.edu/. (B) Whole-
mount in situ hybridization for c-myb and runx1 was performed at 36 hpf on uninjected
embryos or embryos injected with morpholinos (MO) targeting mllt3, gfi1, atf3, tulp4, or
prdm16. Bars in gfi1b panels designate the posterior ICM. (C) The CHT of prdm16
morphants was examined 4 dpf for c-myb/runx1 expression via whole-mount in situ
hybridization. (D) Prdm16 morphants were examined via whole-mount in situ hybridization
for mpo or l-plastin expression at 38 hpf. (E) Prdm16 morphants were examined via whole-
mount in situ hybridization for rag-1 at 4 dpf. See also Figures S6, S7.
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